Table 3.
Alleged location of manufacture | Approval status
|
||
---|---|---|---|
Total | Failed | % fail | |
SRA | |||
Africa | 0 | 0 | N/A |
India | 12 | 0 | 0.00% |
China | 0 | 0 | N/A |
EU/USA | 383 | 4 | 1.04% |
Total | 395 | 4 | 1.01% |
WHO | |||
Africa | 0 | 0 | N/A |
India | 293 | 7 | 2.39% |
China | 119 | 21 | 17.65% |
EU/USA | 0 | 0 | N/A |
Total | 412 | 28 | 6.80% |
Neither SRA or WHO | |||
Africa | 551 | 142 | 25.77% |
India | 883 | 37 | 4.19% |
China | 383 | 58 | 15.14% |
EU/USA | 28 | 3 | 10.71% |
Total | 1845 | 240 | 13.01% |
Total | |||
Africa | 551 | 142 | 25.77% |
India | 1188 | 44 | 3.70% |
China | 502 | 79 | 15.74% |
EU/USA | 411 | 7 | 1.70% |
Total | 2652 | 272 | 10.26% |
Abbreviations: EU, European Union; SRA, stringent regulatory authority; WHO, World Health Organization.